CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands		Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning Balance (in shares) at Feb. 02, 2020			77,137,000
Beginning Balance at Feb. 02, 2020		$ 1,235,860	$ 772	$ 605,822	$ 644,794	$ (14,587)	$ (941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		35,423			35,423
Foreign currency translation adjustments		(5,276)				(5,276)
Change in fair value of derivative financial instruments, net of tax		549				549
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(37)				(37)
Conversion/release of stock-based awards (in shares)	[1]		622,000
Conversion/release of stock-based awards	[1]	(28,912)	$ 6	(28,747)			(171)
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(499)	(14)		513
Stock-based compensation expense		19,608		19,608
Dividends declared		(38,286)			(38,286)
Ending Balance (in shares) at May. 03, 2020			77,759,000
Ending Balance at May. 03, 2020		1,218,929	$ 778	596,184	641,917	(19,351)	(599)
Beginning Balance (in shares) at Feb. 02, 2020			77,137,000
Beginning Balance at Feb. 02, 2020		1,235,860	$ 772	605,822	644,794	(14,587)	(941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		371,759
Foreign currency translation adjustments		716
Change in fair value of derivative financial instruments, net of tax		403
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(375)
Ending Balance (in shares) at Nov. 01, 2020			76,697,000
Ending Balance at Nov. 01, 2020		1,401,902	$ 768	623,379	792,196	(13,843)	(598)
Beginning Balance (in shares) at May. 03, 2020			77,759,000
Beginning Balance at May. 03, 2020		1,218,929	$ 778	596,184	641,917	(19,351)	(599)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		134,564			134,564
Foreign currency translation adjustments		6,737				6,737
Change in fair value of derivative financial instruments, net of tax		(200)				(200)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(107)				(107)
Conversion/release of stock-based awards (in shares)	[1]		37,000
Conversion/release of stock-based awards	[1]	(677)		(677)
Stock-based compensation expense		13,385		13,385
Dividends declared		(39,709)			(39,709)
Ending Balance (in shares) at Aug. 02, 2020			77,796,000
Ending Balance at Aug. 02, 2020		1,332,922	$ 778	608,892	736,772	(12,921)	(599)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		201,772			201,772
Foreign currency translation adjustments		(745)				(745)
Change in fair value of derivative financial instruments, net of tax		54				54
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		(231)				(231)
Conversion/release of stock-based awards (in shares)	[1]		20,000
Conversion/release of stock-based awards	[1]	(966)	$ 1	(968)			1
Repurchases of common stock (in shares)			(1,119,000)
Repurchases of common stock		(109,048)	$ (11)	(5,640)	(103,397)
Stock-based compensation expense		21,095		21,095
Dividends declared		(42,951)			(42,951)
Ending Balance (in shares) at Nov. 01, 2020			76,697,000
Ending Balance at Nov. 01, 2020		1,401,902	$ 768	623,379	792,196	(13,843)	(598)
Beginning Balance (in shares) at Jan. 31, 2021			76,340,000
Beginning Balance at Jan. 31, 2021		1,651,185	$ 764	638,375	1,019,762	(7,117)	(599)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		227,802			227,802
Foreign currency translation adjustments		3,700				3,700
Change in fair value of derivative financial instruments, net of tax		(665)				(665)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		153				153
Conversion/release of stock-based awards (in shares)	[1]		686,000
Conversion/release of stock-based awards	[1]	(98,451)	$ 7	(97,958)			(500)
Repurchases of common stock (in shares)			(1,791,000)
Repurchases of common stock		(315,529)	$ (18)	(9,239)	(306,272)
Reissuance of treasury stock under stock-based compensation plans	[1]	0		(344)	(44)		388
Stock-based compensation expense		25,471		25,471
Dividends declared		(46,370)			(46,370)
Ending Balance (in shares) at May. 02, 2021			75,235,000
Ending Balance at May. 02, 2021		1,447,296	$ 753	556,305	894,878	(3,929)	(711)
Beginning Balance (in shares) at Jan. 31, 2021			76,340,000
Beginning Balance at Jan. 31, 2021		1,651,185	$ 764	638,375	1,019,762	(7,117)	(599)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		723,396
Foreign currency translation adjustments		970
Change in fair value of derivative financial instruments, net of tax		(654)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		859
Ending Balance (in shares) at Oct. 31, 2021			73,326,000
Ending Balance at Oct. 31, 2021		1,543,370	$ 734	585,449	963,840	(5,942)	(711)
Beginning Balance (in shares) at May. 02, 2021			75,235,000
Beginning Balance at May. 02, 2021		1,447,296	$ 753	556,305	894,878	(3,929)	(711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		246,070			246,070
Foreign currency translation adjustments		(3,522)				(3,522)
Change in fair value of derivative financial instruments, net of tax		65				65
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		337				337
Conversion/release of stock-based awards (in shares)	[1]		25,000
Conversion/release of stock-based awards	[1]	(1,709)		(1,709)
Repurchases of common stock (in shares)			(834,000)
Repurchases of common stock		(135,859)	$ (8)	(4,358)	(131,493)
Stock-based compensation expense		19,496		19,496
Dividends declared		(45,455)			(45,455)
Ending Balance (in shares) at Aug. 01, 2021			74,426,000
Ending Balance at Aug. 01, 2021		1,526,719	$ 745	569,734	964,000	(7,049)	(711)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings		249,524			249,524
Foreign currency translation adjustments		792				792
Change in fair value of derivative financial instruments, net of tax		(54)				(54)
Reclassification adjustment for realized (gain) loss on derivative financial instruments, net of tax		369				369
Conversion/release of stock-based awards (in shares)	[1]		20,000
Conversion/release of stock-based awards	[1]	(2,322)		(2,322)
Repurchases of common stock (in shares)			(1,120,000)
Repurchases of common stock		(201,311)	$ (11)	(5,921)	(195,379)
Stock-based compensation expense		23,958		23,958
Dividends declared		(54,305)			(54,305)
Ending Balance (in shares) at Oct. 31, 2021			73,326,000
Ending Balance at Oct. 31, 2021		$ 1,543,370	$ 734	$ 585,449	$ 963,840	$ (5,942)	$ (711)

[1] Amounts are shown net of shares withheld for employee taxes.